Perfume Composition Containing a Derivative of Hydroxy Citronellal
Total Page:16
File Type:pdf, Size:1020Kb
Europaisches Patentamt J European Patent Office © Publication number: 0 251 644 Office europeen des brevets A2 EUROPEAN PATENT APPLICATION © Application number: 87305558.6 C11B © int. Ci.«: 9/00 , A61 K 7/46 © Date of filing: 23.06.87 © Priority: 25.06.86 JP 146993/86 © Applicant: Takasago Perfumery Co., Ltd. No. 19-22, Takanawa 3-chome @ Date of publication of application: Minato-ku Tokyo(JP) 07.01.88 Bulletin 88/01 © Inventor: Yamamotc, Takeshi © Designated Contracting States: Takagaso Perfumery Co. Ltd. Kamata Div. CH DE FR GB IT LI NL 5-36-31 Kamata Ohta-ku Tokyo(JP) Inventor: Sakurai, Kazutoshi Takagaso Perfumery Co. Ltd. Kamata Div. 5-36-31 Kamata Ohta-ku Tokyo(JP) Inventor: Watanabe, Susumu Takagaso Perfumery Co. Ltd. Kamata Div. 5-36-31 Kamata Ohta-ku Tokyo(JP) Inventor: Kinosaki, Atsushi Takagaso Perfumery Co. Ltd. Kamata Div. 5-36-31 Kamata Ohta-ku Tokyo(JP) © Representative: Diamond, Bryan Clive et al Gee & Co. Chancery House Chancery Lane London WC2A 1QU(GB) © Perfume composition containing a derivative of hydroxy citronellal. © A perfume composition contains methyl I-3,7-dimethyl-7-hydroxyoctylideneanthranilate of the following formula (I): CM to (I) Q- LU CH3 fa CH3 Xerox Copy Centre 0 251 644 in an amount of 0.1 to 50 wt%, together with other conventional perfume components. Two synthesis routes are given. The compound has an orange-flower note. The composition is less allergenic and is safer than those containing the corresponding d-or dl-form, and it has a less irritating odor and imparts a clean and green note. 0 251 644 PERFUME COMPOSITION CONTAINING A DERIVATIVE OF HYDROXY CITRONELLAL The present invention relates to a perfume composition and, in particular, to a perfume composition having a low sensitizing potential skin. on __ Methyl 3,7-dimethyl-7-hydroxyoctylideneanthranilate is a Schiff base compound, prepared from hydrox- ycitronellal (3,7-dimethyl-7-hydroxyoctanal) and methyl anthranilate. Hydroxycitronellal used as a starting 5 material for the production of this compound is also a synthetic perfume and has chiefly been available in the form of either d-hydroxycitronellal which is obtained by hydrolysis of a sulfurous acid adduct of d- citronellal derived from citronella oil, or dt-hydroxycitronellal which is prepared from di-citronellal which is itself prepared from myrcene. In other words, an I -form of hydroxycitronellal has seldom been used (see 0. Okuda, Koryo Kagaku Soran (Review of Perfume Chemistry), p. 753, Hirokawa Publishing Company, I968). io Therefore, methyl 3,7-dimethyl-7-hydroxyoctylideneanthranilate has generally been known only in its d- or d£-form. Being a classical fragrance raw material having an orange flower note, methyl 3,7-dimethyl-7- hydroxyoctylideneanthranilate has been recognized as an indispensable aroma chemical that is com- pounded for manufacturing perfumes within the class of the floral family (see Steffen and Arctander, Perfume and Flavor Chemicals Monograph, No. I735 (I969)). However, no case has been reported of 75 success in isolating the I -form of methyl 3,7-dimethyl-7-hydroxyoctylideneanthranilate or in identifying its fragrance and properties. There has also been no report on the characteristics or safety features of this compound as a perfume. With the recent concern over the safety of perfumes, there is a global need to create perfumes that present much less hazard to human health. In this connection, it has been reported that hydroxycitronellal which 20 is not only a synthetic perfume per se but also used as a starting material for the production of methyl 3,7-dimethyl-7-hydroxyoctylideneanthranilate has a potential for causing dermatitis when it is used in a cream base (see H. Nakayama, Perfume Allergy and Patch Test in Perfume Chemistry Books, No. I, Fragrance Journal Publishing Company, p. 78 (I983)). This suggests the possibility that the conventionally used methyl 3,7-dimethyl-7-hydroxyoctylideneanthranilate also has a potential for causing contact allergy. If 25 so, this compound cannot be used in the preparation of perfumes of either the citrus or neroli family. Therefore, development of a substitute that has the closest resemblance to the conventional methyl 3,7- dimethyl-7-hydroxyoctylideneanthranilate not only in terms of fragrance but also with respect to other properties such as solubility is strongly desired. The present inventors synthesized various aldehyde compounds, reacted them with methyl anthranilate 30 to Schiff prepare bases, and investigated the safety and other characteristics of these Schiff bases used as perfumes. During the course of these studies, the present inventors established a method of synthesizing t- hydroxycitronellal (see Japanese Patent Application (OPI) No. 4748/I983) with the attendant finding that the 1-form of hydroxycitronellal has a very low level of allergenicity as compared with its d-form. (The term "OPI" as used herein refers to a "published unexamined Japanese patent application".) 35 In addition to the note of fragrance and solubility of the Schiff bases, the present inventors investigated their to potential cause contact allergy (or sensitization) by conducting an allergenicity test on guinea pigs with view a to searching for a substitute that is safer to use and which yet provides a note of fragrance that is not much different from those of the conventional isomers of hydroxycitronellal. As a result, the present inventors found that only methyl 3,7-dimethyl-7-hydroxyoctylideneanthranilate is acceptable because of its 40 balanced properties, i.e., very low sensitizing potential, note for fragrance that is not much different from those of other isomeric forms of hydroxycitronellal, less irritating odor, cleanness, and an added green note. The present invention has been accomplished on the basis of this finding. The present invention provides a perfume composition containing methyl l-3,7-dimethyl-7-hydroxyoc- tylideneanthranilate of the following formula (I): 45 50 0 251 644 k b=N v (I) 70 CH3 (ijjj CH3 75 The single figure is an infrared spectrum of methyl £-3,7-dimethyl-7-hydroxyoctylideneanthranilate produced in Pretion Example I. Methyl I-3,7-dimethyl-7-hydroxyoctylideneanthranilate represented by formula (I) can be prepared by one of the following two routes: (1) (-)-8-Hydroxy-A4-menthen-3-one derived from ( + )-pulegone is reacted with alkaline hydrogen 20 peroxide to obtain ( + )-8-hydroxy-4,5a-epoxyisomenthone which is then reacted with tosyl hydrazine to form (-)-7-hydroxy-3,7-dimethylocto-5-in-l-al which is subsequently hydrogenated (see Helv. Chimica Acta., 54 , I797 (I97I)); and (2) According to the method described in Example 3 in the specification of Japanese Patent Application (OPI) No. 4748/1983 (EP 0068506) or the method described in J. Am. Chem. Soc. , I06, 5208 25 (I984), N,N-diethyl-7-hydroxygeranylamine ((E)-N,N-diethyl-7-hydroxy-3,7-dimethyl-2-octenylamine) or N,N- diethyl-7-hydroxycinerylamine ((Z)-N,N-diethyl-7-hydroxy-3,7-dimethyl-2-octenylamine) is asymmetrically isomerized with [Rh((+)-BINAP)(NBD)]+CIOr or [Rh((-)-BINAP)(NBD)J+CIOr to form an enamine of (-)-7- hydroxycitronellal which is then hydrolyzed, wherein NBD means norbornadiene, and BINAP means 2,2'-bis- (diphenylphosphono-l,l'-binaphthyl. 30 By employing, either one of these methods, (-)-7-hydroxycitronellal having a boiling point of from 85 to 90°C/2 mmHg and a specific rotation [a] £3 of -12° (C = 20, benzene) is obtained. When this substance is reacted with methyl anthranilate by a known method, the intended methyl l-3,7-dimethyl-7-hydroxyoc- tylideneanthranilate of formula (I) is formed. This substance is a yellow viscous liquid having an orange- flower note. 35 The contact allergenic (or sensitizing) potential of this substance was compared with those of the conventional d-and dt-forms of methyl 3,7-dimethyl-7-hydroxyoctylideneanthraniIate by conducting the following maximization test according to the method described in B. Magnusson and A.M. Kligman, J. Inv. Derm., 52, 268-276 (I976). The results were evaluated after the lapse of a predetermined period. The sensitized potential of guinea 40 pigs that were challenged with the l-form after induction with the it-form was weaker than that of those that were challenged with the d-and dl-forms after induction with the d-and dMorms, respectively. The same results were observed such that the sensitized potential of guinea pigs that were challenged with the d-, dl- , or I-form after induction with the dl-form was weaker than that of those that were challenged with d-, £-, and di-forms after induction with the d-or d£-form. In addition, the sensitized potential of guinea pigs that 45 were challenged with the I -form after induction with the d-or d i-form was also of a weaker level in the cross-reaction. For these reasons, the use of the I-form of methyl 3,7-dimethyl-7-hydroxyoctylideneanth- ranilate is recommended. When this compound, i.e., methyl £-3,7-dimethyl-7-hydroxyoctylideneanthranilate, is used in a perfume composition, it can find extensive utility in the manufacture of compounded perfumes in the citrus or neroli so family that have a fragrance of the same orange-flower note as imparted by the heretofore used isomers. This compound may be used in an amount of from 0.1 to 50 wt%, preferably from 0.5 to 20 wt%,-of the perfume composition. In addition to this active compound, the perfume composition of the present invention may contain commonly employed additives for perfumes in appropriate amounts. The perfume composition may be formulated in any desired dosage form. 55 The following examples and test example are provided for the purpose of further illustrating the present invention but are in no sense to be taken as limiting. 0 251 644 PREPARATION EXAMPLE I72 g (I mole) of l-hydroxycitronellal (prepared in accordance with Example 3 of Japanese Patent Application (OPI) No.